Mei Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mei Wang has a total of 135 co-authors. Here are the top co-authors by number of shared publications:
Wei Zhu
Department of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu Province, China
14 shared publicationsXiaoli Cao
Department of Laboratory Medicine Affiliated Tumor Hospital of Nantong University Nantong China
14 shared publicationsFeng Huang
Department of Clinical Laboratory, Maternal and Child Health Care Hospital of Kunshan, Suzhou, Jiangsu Province 215300, China
10 shared publicationsBaocheng Zhou
Department of Medical Laboratory,Lianyungang Maternal and Child Health Hospital, Lianyungang, Jiangsu Province 222000, China
8 shared publicationsLin Wang
Department of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
8 shared publicationsJiaying Huang
Key Laboratory of Medical Science and Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang, China
7 shared publications
Latest Publications
- 29 October 2026
- Published by Taylor & Francis in Expert Opinion on Therapeutic Targets
- p. 1-12
CCL11 as a cancer target: molecular role and the mechanisms for potential therapeutic intervention
1. First cloned in 1996 as an eosinophil-selective CC chemokine signaling through CC chemokine receptor 3 (CCR3) [1,2], CCL11 (eotaxin-1) has since outgrown its original role in allergic eosinophil...
- 29 October 2026
- Published by Taylor & Francis in Expert Opinion on Therapeutic Targets
- p. 1-12
CCL11 as a cancer target: molecular role and the mechanisms for potential therapeutic intervention
1. First cloned in 1996 as an eosinophil-selective CC chemokine signaling through CC chemokine receptor 3 (CCR3) [1,2], CCL11 (eotaxin-1) has since outgrown its original role in allergic eosinophil...
- 4 July 2026
- Published by Wiley in Cell Biology International
- Vol. 50 (7) , e70179
Small Extracellular Vesicle‐TLN1 Modulates Gastric Cancer Cells and Remodels Lymphatic Endothelial Cells Through AKT Activation to Potentiate Lymphatic Metastasis
Lymph node metastasis is a pivotal determinant of poor prognosis of gastric cancer, but the molecular orchestrators of lymphatic dissemination remain poorly characterized. Recent research highlights the pivotal role of small extracellular vesicles (sEVs) with specific cargo during the process. Herein, TLN1 was identified as being selectively enriched within sEVs from highly lymph‐metastatic gastric cancer cells and in the serum of gastric cancer patients with lymph node metastasis, as identified through proteomic screening and confirmed by western blotting. sEVs act as key autocrine signals that influence gastric cancer cell behaviors such as proliferation, migration, invasion, and adhesion. TLN1 protein levels in cells correlate with their lymphatic metastatic potential and determine TLN1 content in sEVs. Inhibiting TLN1 reduces these cancer cell malignant behaviors and leads to TLN1‐depleted sEVs. TLN1 could be transferred to gastric cancer cells and human lymphatic endothelial cells (HLECs) via sEVs. Without TLN1, sEVs cannot enhance cancer cell malignancy or induce HLEC proliferation, tube formation, adhesion, permeability in vitro, or lymphatic metastasis in vivo. Mechanistically, AKT activation was identified as a mediator of the effects exerted by sEV‐TLN1 on both gastric cancer cells and HLECs. In conclusion, TLN1 orchestrates lymphatic metastasis in gastric cancer by dual‐modulating tumor cell malignancy and lymphatic vessel remodeling via AKT activation. This discovery offers new perspectives on the mechanisms driving lymphatic metastasis in gastric cancer and proposes a promising target for the detection and therapeutic intervention of lymph node metastasis.
- 4 July 2026
- Published by Wiley in Cell Biology International
- Vol. 50 (7) , e70179
Small Extracellular Vesicle‐TLN1 Modulates Gastric Cancer Cells and Remodels Lymphatic Endothelial Cells Through AKT Activation to Potentiate Lymphatic Metastasis
Lymph node metastasis is a pivotal determinant of poor prognosis of gastric cancer, but the molecular orchestrators of lymphatic dissemination remain poorly characterized. Recent research highlights the pivotal role of small extracellular vesicles (sEVs) with specific cargo during the process. Herein, TLN1 was identified as being selectively enriched within sEVs from highly lymph‐metastatic gastric cancer cells and in the serum of gastric cancer patients with lymph node metastasis, as identified through proteomic screening and confirmed by western blotting. sEVs act as key autocrine signals that influence gastric cancer cell behaviors such as proliferation, migration, invasion, and adhesion. TLN1 protein levels in cells correlate with their lymphatic metastatic potential and determine TLN1 content in sEVs. Inhibiting TLN1 reduces these cancer cell malignant behaviors and leads to TLN1‐depleted sEVs. TLN1 could be transferred to gastric cancer cells and human lymphatic endothelial cells (HLECs) via sEVs. Without TLN1, sEVs cannot enhance cancer cell malignancy or induce HLEC proliferation, tube formation, adhesion, permeability in vitro, or lymphatic metastasis in vivo. Mechanistically, AKT activation was identified as a mediator of the effects exerted by sEV‐TLN1 on both gastric cancer cells and HLECs. In conclusion, TLN1 orchestrates lymphatic metastasis in gastric cancer by dual‐modulating tumor cell malignancy and lymphatic vessel remodeling via AKT activation. This discovery offers new perspectives on the mechanisms driving lymphatic metastasis in gastric cancer and proposes a promising target for the detection and therapeutic intervention of lymph node metastasis.
- 15 June 2026
- Published by Elsevier in Cellular Signalling
- Vol. 146, 112676
FOLR2+ tumor-associated macrophages drive metastatic microenvironment remodeling and lymphatic dissemination in colorectal cancer
- 15 June 2026
- Published by Elsevier in Cellular Signalling
- Vol. 146, 112676
FOLR2+ tumor-associated macrophages drive metastatic microenvironment remodeling and lymphatic dissemination in colorectal cancer
- 1 April 2026
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 67 (6) , 1231-1246
Single-cell technologies in deciphering drug resistance of multiple myeloma: mechanistic insights and clinical translation prospects
The greatest hindrance to long-lasting remission in multiple myeloma (MM) is drug resistance and is modulated by the complex interaction of tumor-intrinsic plasticity and microenvironmental co-evolution. Multi-omics of single cells has transformed the exploration of this complexity, and has solved the dynamics of clonal architecture and ecosystem at an unprecedented resolution. The present review summarizes critical relapse-driver revealed by single cell technologies, including existing resistant subclones and non-genetic programs, as well as inflammatory stromal remodeling and immune exhaustion. We also discuss the problem of reproducibility crisis due to analytical heterogeneity critically, outlining computational best practices to distinguish robust biological signals to technical artifacts. Moreover, we comment on the translational imperative, emphasizing new target discovery, rational combination strategies and mechanism-based prognostic modeling. Ultimately, high-fidelity molecular profiling needs to be bridged with strict analytical principles to make precision oncology advance in MM.
- 1 April 2026
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 67 (6) , 1231-1246
Single-cell technologies in deciphering drug resistance of multiple myeloma: mechanistic insights and clinical translation prospects
The greatest hindrance to long-lasting remission in multiple myeloma (MM) is drug resistance and is modulated by the complex interaction of tumor-intrinsic plasticity and microenvironmental co-evolution. Multi-omics of single cells has transformed the exploration of this complexity, and has solved the dynamics of clonal architecture and ecosystem at an unprecedented resolution. The present review summarizes critical relapse-driver revealed by single cell technologies, including existing resistant subclones and non-genetic programs, as well as inflammatory stromal remodeling and immune exhaustion. We also discuss the problem of reproducibility crisis due to analytical heterogeneity critically, outlining computational best practices to distinguish robust biological signals to technical artifacts. Moreover, we comment on the translational imperative, emphasizing new target discovery, rational combination strategies and mechanism-based prognostic modeling. Ultimately, high-fidelity molecular profiling needs to be bridged with strict analytical principles to make precision oncology advance in MM.
- 28 March 2026
- Published by Elsevier in Pathology - Research and Practice
- Vol. 282, 156461
Targeting the syncytiotrophoblast: A central player in the pathogenesis and therapy of preeclampsia
- 28 March 2026
- Published by Elsevier in Pathology - Research and Practice
- Vol. 282, 156461
Targeting the syncytiotrophoblast: A central player in the pathogenesis and therapy of preeclampsia
- 8 January 2026
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 28 (6) , 1986-1997
Integrins as key regulators in tumor perineural invasion: mechanisms and clinical implications
Perineural invasion (PNI) serves as an important prognostic indicator in various solid tumors, closely associated with tumor recurrence and reduced survival rates. At present, the molecular mechanisms of initiating PNI have been extensively studied but still lack targets employed for efficient diagnosis and treatment clinically. The integrins’ family is major cell adhesion receptors linking the cytoskeleton to the extracellular matrix (ECM) and mediating bidirectional signaling involved in tumor development. Recently, emerging evidence has emphasized the crucial role of integrins in PNI. To comprehensively understand its potential regulatory mechanisms and application prospects, this review summarizes the latest research on integrins affecting PNI, covering their molecular characteristics, oncogenic mechanisms, and clinical significance. In addition, we also point out the current challenges and propose innovative strategies to promote the advancement of tumor diagnosis, prognosis prediction, and therapeutic strategies.
- 8 January 2026
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 28 (6) , 1986-1997
Integrins as key regulators in tumor perineural invasion: mechanisms and clinical implications
Perineural invasion (PNI) serves as an important prognostic indicator in various solid tumors, closely associated with tumor recurrence and reduced survival rates. At present, the molecular mechanisms of initiating PNI have been extensively studied but still lack targets employed for efficient diagnosis and treatment clinically. The integrins’ family is major cell adhesion receptors linking the cytoskeleton to the extracellular matrix (ECM) and mediating bidirectional signaling involved in tumor development. Recently, emerging evidence has emphasized the crucial role of integrins in PNI. To comprehensively understand its potential regulatory mechanisms and application prospects, this review summarizes the latest research on integrins affecting PNI, covering their molecular characteristics, oncogenic mechanisms, and clinical significance. In addition, we also point out the current challenges and propose innovative strategies to promote the advancement of tumor diagnosis, prognosis prediction, and therapeutic strategies.
- 21 August 2025
- Published by Elsevier in Biochemical Pharmacology
- Vol. 242 (Pt 1) , 117255
Decoding the roles of CCL11 in human malignancies and clinical implications
- 21 August 2025
- Published by Elsevier in Biochemical Pharmacology
- Vol. 242 (Pt 1) , 117255
Decoding the roles of CCL11 in human malignancies and clinical implications
- 4 August 2025
- Published by Springer Nature in In Vitro Cellular & Developmental Biology - Animal
- Vol. 61 (9) , 1071-1081
KHDRBS3-mediated upregulation of circ_0024107 in gastric cancer cells and GC-MSCs synergistically drives gastric cancer cell migration and invasion
Gastric cancer is a significant global health concern due to its high morbidity and mortality. Gastric cancer-associated mesenchymal stem cells (GC-MSCs) significantly contribute to its progression, with circ_0024107 being notably elevated in these cells and essential for their tumor-promoting activities. However, the expression and function of this circRNA in gastric cancer cells as well as its upstream regulators remain unclear. qPCR was used to assess circ_0024107 expression levels. Gain- and loss-of-function experiments evaluated its roles. Transwell assays measured cell migration and invasion. KHDRBS3 was predicted and validated through database analysis and qPCR, and its effects on circ_0024107 were analyzed using qPCR and transwell assays. The expression and clinical implications of KHDRBS3 in gastric cancer were evaluated using the TCGA-STAD database. circ_0024107 expression was elevated in gastric cancer cells, where it promotes migration and invasion. GC-MSCs further enhanced these capabilities by upregulating circ_0024107. KHDRBS3 was identified and validated as a regulator of circ_0024107 expression in both gastric cancer cells and GC-MSCs. Knocking down KHDRBS3 significantly reduced circ_0024107 levels, hindering gastric cancer cell migration and invasion, and weakening the influence of GC-MSCs on tumor cells. KHDRBS3 was abnormally elevated in gastric cancer tissues and correlated with patients’ poor prognosis. KHDRBS3-mediated upregulation of circ_0024107 in gastric cancer cells and GC-MSCs synergistically enhances gastric cancer progression. This elucidates novel molecular interactions between GC-MSCs and gastric cancer cells, thereby presenting a promising therapeutic target for effectively mitigating gastric cancer metastasis.
- 4 August 2025
- Published by Springer Nature in In Vitro Cellular & Developmental Biology - Animal
- Vol. 61 (9) , 1071-1081
KHDRBS3-mediated upregulation of circ_0024107 in gastric cancer cells and GC-MSCs synergistically drives gastric cancer cell migration and invasion
Gastric cancer is a significant global health concern due to its high morbidity and mortality. Gastric cancer-associated mesenchymal stem cells (GC-MSCs) significantly contribute to its progression, with circ_0024107 being notably elevated in these cells and essential for their tumor-promoting activities. However, the expression and function of this circRNA in gastric cancer cells as well as its upstream regulators remain unclear. qPCR was used to assess circ_0024107 expression levels. Gain- and loss-of-function experiments evaluated its roles. Transwell assays measured cell migration and invasion. KHDRBS3 was predicted and validated through database analysis and qPCR, and its effects on circ_0024107 were analyzed using qPCR and transwell assays. The expression and clinical implications of KHDRBS3 in gastric cancer were evaluated using the TCGA-STAD database. circ_0024107 expression was elevated in gastric cancer cells, where it promotes migration and invasion. GC-MSCs further enhanced these capabilities by upregulating circ_0024107. KHDRBS3 was identified and validated as a regulator of circ_0024107 expression in both gastric cancer cells and GC-MSCs. Knocking down KHDRBS3 significantly reduced circ_0024107 levels, hindering gastric cancer cell migration and invasion, and weakening the influence of GC-MSCs on tumor cells. KHDRBS3 was abnormally elevated in gastric cancer tissues and correlated with patients’ poor prognosis. KHDRBS3-mediated upregulation of circ_0024107 in gastric cancer cells and GC-MSCs synergistically enhances gastric cancer progression. This elucidates novel molecular interactions between GC-MSCs and gastric cancer cells, thereby presenting a promising therapeutic target for effectively mitigating gastric cancer metastasis.